Pfizer CEO says there will be no generic Paxlovid for China

Pfizer CEO Dismisses Reports of a Paxlovid Generic for China

Pfizer CEO Dismisses Reports of a Paxlovid Generic for China - The U.S. pharmaceutical giant is working on starting domestic production of the branded version of the Covid drug in the first half of this year

Pfizer CEO rules out generic COVID drug Paxlovid for China

Pfizer CEO rules out generic COVID-19 drug Paxlovid for China

Pfizer chief executive Albert Bourla says 'We are not in discussions. We have an agreement already for local manufacturing of Paxlovid in China.'

Pfizer working to send COVID pill Paxlovid to China

(Reuters) – Pfizer Inc is working with Chinese authorities to send its COVID-19 pill, Paxlovid, to the country that is dealing with a surge in COVID-19 cases, Chief Executive Officer Albert Bourla said in an interview with CNBC on Monday. In February last year, China approved Paxlovid to treat high-risk patients in several provinces. The drug was supposed to be largely available via hospitals. Pfizer has also reached an agreement to export Paxlo…

Pfizer CEO says there will be no generic Paxlovid for China

Bourla said the company had shipped thousands of courses of the treatment in 2022 to China and in the past couple of weeks, had increased that to millions.

Pfizer CEO says there will be no generic Paxlovid for China

BEIJING, Jan 10 ― Pfizer Inc is not in talks with Chinese authorities to license a generic version of its Covid-19 treatment Paxlovid for use there, but is in discussions about a price for the branded product, Chief Executive Albert Bourla said yesterday. Reuters reported on Friday that China was in talks with Pfizer to secure a licence that will allow domestic drugmakers to manufacture and distribute a generic version of the US firm's Covid-19 …